Device for capturing circulating cells
The present invention provides devices and methods for capturing rare cells. The devices and methods described herein can be used to facilitate the diagnosis and monitoring of metastatic cancers.
1. A method of selectively isolating biological cells from a cell sample comprising:
contacting the cell sample to a device for capturing biological cells under conditions that permit binding agents of the device to selectively bind a subpopulation of biological cells, resulting in bound biological cells; and
removing unbound biological cells from the device,
wherein the device comprises:
a substrate comprising a nanostructured surface region;
a plurality of binding agents attached to the nanostructured surface region of the substrate; and
a flow layer attached to said substrate to form a microfluidic channel such that at least a portion of said nanostructured surface region of said substrate is in contact with fluid that flows through said microfluidic channel while in operation,
wherein the nanostructured surface region comprises a plurality of nanostructures each having a longitudinal dimension and lateral dimension, the longitudinal dimension being at least ten times greater than the lateral dimension,
wherein biological cells are selectively captured by the binding agents and the plurality of nanostructures acting in cooperation,
wherein said flow layer comprises a textured surface that causes chaotic flow to increase the probability that said biological cells come into contact with said nanostructured surface region of said substrate to be captured.
2. A method according to claim 1 , further comprising washing the captured biological cells with an aqueous medium.
3. A method according to claim 1 , wherein the cell sample comprises one or more of body fluid, plasma, saliva, spinal fluid, and urine.
4. A method according to claim 1 , wherein the subpopulation of biological cells comprises circulating tumor cells.
5. A method of selectively isolating at least one target biological cell from a cell sample comprising:
providing a cell sample containing at least one target biological cell;
providing a device comprising:
a substrate comprising a nanostructured surface region;
a plurality of binding agents attached to the nanostructured surface region of the substrate; and
a flow layer attached to said substrate to form a microfluidic channel such that at least a portion of said nanostructured surface region of said substrate is in contact with fluid that flows through said microfluidic channel while in operation,
wherein the nanostructured surface region comprises a plurality of nanostructures each having a longitudinal dimension and lateral dimension, the longitudinal dimension being at least ten times greater than the lateral dimension,
wherein biological cells are selectively captured by the binding agents and the plurality of nanostructures acting in cooperation,
wherein said flow layer comprises a textured surface that causes chaotic flow to increase the probability that said biological cells come into contact with said nanostructured surface region of said substrate to be captured;
contacting the cell sample to a plurality of nanostructures to result in the target biological cell(s) being captured,
under conditions effective for the target biological cell(s) to bind to the binding agents attached to the nanostructures, resulting in bound biological cell(s).
6. A method according to claim 5 , further comprising washing the bound biological cell(s) with an aqueous medium.
7. A method according to claim 5 , further comprising detecting the presence of the target biological cell(s).
8. A method according to claim 5 , wherein the cell sample comprises one or more of body fluid, plasma, saliva, spinal fluid, and urine.
9. A method according to claim 5 , wherein the target biological cell(s) comprises a circulating tumor cell(s).
10. A method according to claim 5 , wherein the plurality of binding agents comprises one or more of DNA, peptides, aptamers, and antibodies.
11. A method according to claim 5 , wherein said plurality of binding agents comprises a plurality of over-expressed antibodies for tumor cells.
12. A method according to claim 5 , wherein said plurality of binding agents is a plurality of anti-epithelial-cell adhesion molecule antibodies (anti-EpCAM).
13. A method according to claim 5 , wherein said plurality of binding agents is a plurality of antibodies for immune cells.